> Introducing the Project > Project Contents > 5th Human Studies
- Objectives
- Development of clinical trials technology based on cutting-edge fusion technologies including nutrigenomics, metabolomics, and system biology, for testing safety / efficacy of MCMT
- Details
- Standardization of MCMT specific verification methodology for clinical trials
- Development of MCMT clinical trial models for chronic diseases that share the similar molecular mechanisms
- Construction of international network for clinical trials, and verification of new genome-bio-marker panels based on the mass clinical trials
- Verification of natural compounds efficacy that have been investigated by virtual human body model simulation system
- Design of personalized nutrition / personalized food industrialization model based on sensitive genes for the disease, using the international networks
- Process Orders
- Prospects
- Development of tailored natural materials through verification of bio-marker batteries for genomes / metabolites of chronic diseases, establishment of standardized clinical trial techniques, and construction of mass production system of CTM (clinical trial materials)
- With verified virtual human cell models, reduce cost and duration in developing MC/MT based tailored natural materials
- Creation of new industrial engine by creating medicinal heritage based tailored nutritional / food production technology
- Enhancement of national competency in biomaterial related industries by securing regional raw materials, according to biological sovereignty principle stipulated in the Nagoya Protocol
